Management consideration in nonpulmonary visceral metastatic seminoma of testis.

por Park, D. S., Prow, D. M., Amato, R. J., Logothetis, C. J.
Publicado 1999

P1642: OUTCOMES IN HOSPITALIZED PATIENTS WITH COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY

por Logothetis, C., Finley, K., Huang, S., Wood, A., Laber, D., Eatrides, J.
Publicado 2022

Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor

por Horti, J, Dixon, S C, Logothetis, C J, Guo, Y, Reed, E, Figg, W D
Publicado 1999

Effect of Paget’s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis

por Tu, S-M, Som, A, Tu, B, Logothetis, C J, Lee, M-H, Yeung, S-CJ
Publicado 2012

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials

por Som, A, Tu, S-M, Liu, J, Wang, X, Qiao, W, Logothetis, C, Corn, P G
Publicado 2012

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival i...

por Mathew, P, Thall, P F, Wen, S, Bucana, C, Jones, D, Horne, E, Oh, W K, Morris, M J, Lee, Y-C, Logothetis, C J, Lin, S-H, Fidler, I J
Publicado 2008

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours

por Fizazi, K, Prow, D M, Do, K-A, Wang, X, Finn, L, Kim, J, Daliani, D, Papandreou, C N, Tu, S-M, Millikan, R E, Pagliaro, L C, Logothetis, C J, Amato, R J
Publicado 2002

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties

por Paranjape, A N, Soundararajan, R, Werden, S J, Joseph, R, Taube, J H, Liu, H, Rodriguez-Canales, J, Sphyris, N, Wistuba, I, Miura, N, Dhillon, J, Mahajan, N, Mahajan, K, Chang, J T, Ittmann, M, Maity, S N, Logothetis, C, Tang, D G, Mani, S A
Publicado 2016

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

por Gillessen, S., Omlin, A., Attard, G., de Bono, J. S., Efstathiou, E., Fizazi, K., Halabi, S., Nelson, P. S., Sartor, O., Smith, M. R., Soule, H. R., Akaza, H., Beer, T. M., Beltran, H., Chinnaiyan, A. M., Daugaard, G., Davis, I. D., De Santis, M., Drake, C. G., Eeles, R. A., Fanti, S., Gleave, M. E., Heidenreich, A., Hussain, M., James, N. D., Lecouvet, F. E., Logothetis, C. J., Mastris, K., Nilsson, S., Oh, W. K., Olmos, D., Padhani, A. R., Parker, C., Rubin, M. A., Schalken, J. A., Scher, H. I., Sella, A., Shore, N. D., Small, E. J., Sternberg, C. N., Suzuki, H., Sweeney, C. J., Tannock, I. F., Tombal, B.
Publicado 2015